Boothbay Fund Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
+2,606
New +$1.46M 0.02% 920
2026
Q1
– Sell
-413
Closed -$279K – 2251
2025
Q4
$279K Buy
+413
New +$281K ﹤0.01% 1478
2025
Q3
– Sell
-506
Closed -$271K – 2001
2025
Q2
$271K Buy
+506
New +$242K 0.01% 1144
2024
Q4
– Sell
-607
Closed -$307K – 1692
2024
Q3
$307K Sell
607
-122
-17% -$59.3K 0.01% 1224
2024
Q2
$355K Buy
729
+244
+50% +$122K 0.01% 1103
2024
Q1
$262K Buy
+485
New +$265K 0.01% 1244
2018
Q2
– Sell
-2,318
Closed -$444K – 811
2018
Q1
$444K Buy
2,318
+818
+55% +$151K 0.05% 355
2017
Q4
$235K Sell
1,500
-302
-17% -$47.5K 0.03% 527
2017
Q3
$280K Sell
1,802
-2,197
-55% -$347K 0.05% 400
2017
Q2
$646K Buy
+3,999
New +$649K 0.13% 169
2016
Q4
– Sell
-2,137
Closed -$241K – 842
2016
Q3
$241K Buy
+2,137
New +$225K 0.05% 472

Other funds holding IDXX

Boothbay Fund Management's IDXX Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 2,606 shares worth $1.37M. The stake represents 0.02% of the portfolio and ranks #920 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in IDXX as recently as Q4 2025.

Boothbay Fund Management first reported a position in IDXX in Q3 2016 and has held it in 11 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Boothbay Fund Management held 2,606 shares of Idexx Laboratories worth $1.37M as of Q2 2026.
  • Idexx Laboratories was a new Boothbay Fund Management position in Q2 2026.
  • Idexx Laboratories made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #920 holding.
  • Boothbay Fund Management first reported a position in Idexx Laboratories in Q3 2016 and has held it in 11 quarters since.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.